List of articles with "AbbVie"

AbbVie at Healthcare Conference

2026-05-06 12:22:57

United States Healthcare Conference pharmaceuticals AbbVie North Chicago

AbbVie IBD Treatment Data

2026-05-05 12:12:48

None Chicago AbbVie Skyrizi RINVOQ

AbbVie at AAD 2026

2026-04-30 02:40:10

USA Denver AbbVie Upadacitinib Risankizumab

AbbVie Q1 2026 Results

2026-04-29 11:50:19

USA AbbVie North Chicago Skyrizi RINVOQ

FDA Approval Request

2026-04-27 12:12:21

USA Crohn's Disease AbbVie North Chicago Skyrizi

Weekly Press Highlights

2026-04-24 10:07:29

USA New York PR Newswire Red Lobster AbbVie

AbbVie Updates on TrenibotE

2026-04-23 20:11:16

United States FDA AbbVie North Chicago TrenibotulinumtoxinE

AbbVie Expands to North Carolina

2026-04-22 16:09:12

United States Manufacturing Durham AbbVie

AbbVie Launches Aquipta

2026-04-17 01:28:17

Japan Tokyo AbbVie Migraine AQUIPTA

Haisco and AbbVie Partnership

2026-04-13 06:27:14

AbbVie pain therapy Haisco

AbbVie ELAHERE® Data

2026-04-12 11:23:17

United States San Juan AbbVie ELAHERE OvarianCancer

AbbVie at AAD 2026

2026-03-27 14:17:36

AbbVie Upadacitinib Risankizumab

CollPlant Financials 2025

2026-03-26 12:57:44

Israel CollPlant rhCollagen Rehovot AbbVie

FDA Approves Venetoclax

2026-03-25 02:54:06

United States AbbVie North Chicago CLL venetoclax

AbbVie Upadacitinib News

2026-03-23 05:27:22

Japan Tokyo AbbVie Upadacitinib Takayasu Arteritis

Skin Quality Index Launch

2026-03-16 12:12:02

USA Irvine AbbVie Allergan Aesthetics Skin Quality Index

AbbVie Upadacitinib

2026-03-13 05:29:46

Japan Tokyo AbbVie Upadacitinib Vitiligo

ABBV-295 Weight Loss

2026-03-09 12:34:55

USA Weight Management AbbVie North Chicago ABBV-295

Ubadacitinib Approval

2026-02-25 03:06:19

United States AbbVie North Chicago Vitiligo Ubadacitinib

AbbVie $380M Investment

2026-02-23 16:05:04

United States Active Pharmaceutical Ingredient AbbVie North Chicago

AbbVie Quarterly Dividend

2026-02-19 15:22:58

United States Dividend AbbVie North Chicago NYSE ABBV

AbbVie Aquipta Approval

2026-02-19 06:03:26

Japan Tokyo AbbVie Migraine AQUIPTA

AbbVie 2025 Financial Results

2026-02-04 12:56:10

United States AbbVie North Chicago Skyrizi IPRD

RINVOQ® Approval for Vitiligo

2026-02-03 13:11:50

USA AbbVie North Chicago RINVOQ Vitiligo

Biotech's $170B Patent Shift

2026-01-30 15:46:04

None Oncolytics Biotech AbbVie Genmab

Epcoritamab Phase 3 Results

2026-01-16 18:45:38

USA Epcoritamab AbbVie North Chicago DLBCL

AbbVie and Trump Agreement

2026-01-12 23:41:17

USA AbbVie North Chicago TrumpRx ALPHAGAN

AbbVie and RemeGen License Agreement

2026-01-12 12:43:48

United States AbbVie North Chicago RemeGen RC148

AbbVie Expands Arizona Facility

2026-01-12 11:04:15

United States Manufacturing Tempe Arizona AbbVie

West Transfers SmartDose® Rights

2026-01-12 11:02:59

United States Exton AbbVie West Pharmaceutical SmartDose

AbbVie Atogepant Approval

2025-12-15 05:14:05

Japan Tokyo AbbVie Migraine Atogepant

Upadacitinib for Alopecia

2025-12-15 05:13:44

Japan Tokyo AbbVie Alopecia Areata Upadacitinib

I Know IBD Wins Bronze

2025-12-11 02:36:38

Japan AbbVie Minato IBD Awareness I Know IBD

Atogepant Trial Insights

2025-12-10 05:29:28

USA AbbVie North Chicago Migraine Atogepant

AbbVie ASH 2025 Highlights

2025-12-02 14:03:02

United States Chicago Blood Cancer AbbVie ASH 2025

ECLIPSE Study Insights

2025-12-02 08:28:21

USA AbbVie North Chicago Eclipse Atogepant

AbbVie ECLIPSE Migraine Data

2025-12-01 17:27:57

USA AbbVie North Chicago Eclipse Atogepant

Atogepant ECLIPSE Results

2025-12-01 09:16:29

United States AbbVie North Chicago Atogepant ECLIPSE Study

Upadacitinib Phase 3 Results

2025-11-27 05:58:28

United States AbbVie North Chicago Upadacitinib Non-Segmental Vitiligo

AbbVie at Conference

2025-11-24 13:16:05

United States healthcare AbbVie North Chicago Piper Sandler

New CLL/SLL Treatment

2025-11-20 06:14:28

Japan Tokyo AbbVie CLL venetoclax

AbbVie EPKINLY Approval

2025-11-18 18:21:29

United States AbbVie North Chicago Lymphoma EPKINLY

AbbVie Film on Resilience

2025-11-14 17:43:00

United States Los Angeles AbbVie CLL Second Winds

AbbVie Migraine Award Recipients

2025-11-13 14:14:50

United States AbbVie North Chicago resilience Migraine Career Catalyst Award

2026 Best Places to Work

2025-11-04 08:17:19

United States BridgeBio Des Moines AbbVie BioSpace

AbbVie Q3 2025 Review

2025-10-31 12:00:56

United States AbbVie North Chicago Skyrizi RINVOQ

Pediatric Risankizumab

2025-10-29 05:16:48

Japan pediatric psoriasis AbbVie Minato-ku Risankizumab

AbbVie Acquires Bretisilocin

2025-10-17 13:23:47

USA AbbVie North Chicago Gilgamesh Pharmaceuticals Bretisilocin

RINVOQ® Approval

2025-10-13 15:00:58

USA AbbVie North Chicago IBD RINVOQ

AbbVie ADC Data ESMO

2025-10-13 11:21:34

United States ADC AbbVie North Chicago Solid Tumors